Revenue is expected to range between $350 million and $410 million. GAAP gross margin is forecasted to be between 51 percent and 53 percent. Combined GAAP R&D and SG&A expenses are anticipated to range between $141 million and $147 million, including approximately $20 million in stock-based compensation expense and $2 million in amortization of acquired intangibles, resulting in a non-GAAP operating expense range between $119 million and $125 million.